

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.40473189 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.40473189 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.70075675 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.38263225 |
| 5 | * cellular response to type I interferon (GO:0071357) | 6.28790349 |
| 6 | * type I interferon signaling pathway (GO:0060337) | 6.28790349 |
| 7 | * response to type I interferon (GO:0034340) | 6.26392397 |
| 8 | response to interferon-alpha (GO:0035455) | 5.50342917 |
| 9 | * positive regulation of interferon-alpha production (GO:0032727) | 4.87483532 |
| 10 | * regulation of interferon-alpha production (GO:0032647) | 4.60494429 |
| 11 | cellular response to interferon-alpha (GO:0035457) | 4.58854256 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51399271 |
| 13 | negative regulation of viral genome replication (GO:0045071) | 4.50743448 |
| 14 | response to interferon-beta (GO:0035456) | 4.46255984 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.44489597 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38976416 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38976416 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.38976416 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38976416 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.38976416 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38976416 |
| 22 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.32744717 |
| 23 | detection of bacterium (GO:0016045) | 4.28825873 |
| 24 | detection of other organism (GO:0098543) | 4.27251186 |
| 25 | * positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.21570204 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.16012953 |
| 27 | cellular response to interferon-beta (GO:0035458) | 4.11987211 |
| 28 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.01100503 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.96531327 |
| 30 | T cell migration (GO:0072678) | 3.91814245 |
| 31 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76498128 |
| 32 | regulation of RIG-I signaling pathway (GO:0039535) | 3.66594920 |
| 33 | positive regulation of type 2 immune response (GO:0002830) | 3.64650380 |
| 34 | response to peptidoglycan (GO:0032494) | 3.59606583 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58474268 |
| 36 | germinal center formation (GO:0002467) | 3.57786657 |
| 37 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.56555793 |
| 38 | * immunoglobulin mediated immune response (GO:0016064) | 3.56257995 |
| 39 | regulation of response to interferon-gamma (GO:0060330) | 3.55733103 |
| 40 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.51830560 |
| 41 | * cellular response to interferon-gamma (GO:0071346) | 3.45854018 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.44770123 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.43137978 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.42552146 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.42091563 |
| 46 | defense response to virus (GO:0051607) | 3.36531754 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36341796 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.36242581 |
| 49 | cellular response to exogenous dsRNA (GO:0071360) | 3.35288075 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.34467868 |
| 51 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.30305846 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.29114599 |
| 53 | * positive regulation of interferon-beta production (GO:0032728) | 3.28925975 |
| 54 | respiratory burst (GO:0045730) | 3.27897422 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26785966 |
| 56 | response to host immune response (GO:0052572) | 3.26785966 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25945380 |
| 58 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.24256519 |
| 59 | regulation of type 2 immune response (GO:0002828) | 3.24157099 |
| 60 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.22400776 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22065945 |
| 62 | * response to interferon-gamma (GO:0034341) | 3.21649905 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21380865 |
| 64 | defense response to protozoan (GO:0042832) | 3.19113958 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16296225 |
| 66 | T-helper 1 type immune response (GO:0042088) | 3.15231460 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.15062767 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11312227 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.10977136 |
| 70 | lymphocyte chemotaxis (GO:0048247) | 3.10750414 |
| 71 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09143042 |
| 72 | macrophage activation involved in immune response (GO:0002281) | 3.08284946 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 3.08253790 |
| 74 | negative regulation of innate immune response (GO:0045824) | 3.07782393 |
| 75 | positive regulation of humoral immune response (GO:0002922) | 3.06812065 |
| 76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.06613694 |
| 77 | leukocyte aggregation (GO:0070486) | 3.05512894 |
| 78 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.02181158 |
| 79 | detection of biotic stimulus (GO:0009595) | 3.01122022 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00567210 |
| 81 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.99658980 |
| 82 | natural killer cell mediated immunity (GO:0002228) | 2.99658980 |
| 83 | regulation of interleukin-12 production (GO:0032655) | 2.98751670 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 2.98219856 |
| 85 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.97365115 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94807437 |
| 87 | positive regulation of interleukin-12 production (GO:0032735) | 2.93714995 |
| 88 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93502100 |
| 89 | response to host (GO:0075136) | 2.93502100 |
| 90 | response to host defenses (GO:0052200) | 2.93502100 |
| 91 | neutrophil activation (GO:0042119) | 2.93438190 |
| 92 | negative regulation of type 2 immune response (GO:0002829) | 2.92316501 |
| 93 | detection of molecule of bacterial origin (GO:0032490) | 2.92106378 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.90063696 |
| 95 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89934340 |
| 96 | * B cell mediated immunity (GO:0019724) | 2.88799499 |
| 97 | response to protozoan (GO:0001562) | 2.87881063 |
| 98 | tolerance induction (GO:0002507) | 2.87783908 |
| 99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87738272 |
| 100 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86412082 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.85522712 |
| 102 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85372826 |
| 103 | negative thymic T cell selection (GO:0045060) | 2.84041894 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83859536 |
| 105 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.82254420 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.82242713 |
| 107 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.81685984 |
| 108 | negative regulation of viral process (GO:0048525) | 2.81008746 |
| 109 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.79225299 |
| 110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77810455 |
| 111 | natural killer cell activation involved in immune response (GO:0002323) | 2.77502230 |
| 112 | regulation of T cell tolerance induction (GO:0002664) | 2.76279542 |
| 113 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.75710919 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.75507177 |
| 115 | cellular response to zinc ion (GO:0071294) | 2.74885478 |
| 116 | macrophage activation (GO:0042116) | 2.74816767 |
| 117 | negative regulation of type I interferon production (GO:0032480) | 2.74042165 |
| 118 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73995513 |
| 119 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.72960250 |
| 120 | negative T cell selection (GO:0043383) | 2.72281202 |
| 121 | regulation of viral genome replication (GO:0045069) | 2.71468028 |
| 122 | lymphocyte migration (GO:0072676) | 2.65454664 |
| 123 | JAK-STAT cascade (GO:0007259) | 2.64764314 |
| 124 | positive regulation of response to biotic stimulus (GO:0002833) | 2.62965536 |
| 125 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.62915197 |
| 126 | granulocyte activation (GO:0036230) | 2.62527324 |
| 127 | cellular extravasation (GO:0045123) | 2.62300515 |
| 128 | positive regulation of interleukin-17 production (GO:0032740) | 2.61831513 |
| 129 | negative regulation of cell killing (GO:0031342) | 2.61753300 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61753300 |
| 131 | regulation of chemokine biosynthetic process (GO:0045073) | 2.59674540 |
| 132 | dendritic cell differentiation (GO:0097028) | 2.59397649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.79897645 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.41921106 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.10530343 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.91700593 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.10794767 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57695575 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28935573 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.10084832 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08460625 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00848662 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94560599 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.80050693 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79305406 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.72410941 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55494977 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.45536500 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38239248 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15444131 |
| 19 | * MAF_26560356_Chip-Seq_TH1_Human | 2.14692123 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.10562369 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05705971 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04528310 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02602868 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.02556567 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.99774014 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96059171 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88411768 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82405683 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.75682857 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.73724009 |
| 31 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.72650385 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72407333 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.71738539 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71364788 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68126370 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59082513 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57609857 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55875804 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54565255 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54344817 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.51174882 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48141237 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47934709 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46080089 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41803261 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40622325 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39393205 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39050646 |
| 49 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38619559 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35436536 |
| 51 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.32669942 |
| 52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32266501 |
| 53 | * MAF_26560356_Chip-Seq_TH2_Human | 1.30289200 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29818559 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26292867 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25312672 |
| 57 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.24643346 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23586133 |
| 59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22095061 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20805322 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.20260688 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18646310 |
| 63 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.17198179 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14864663 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13622178 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13215121 |
| 67 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12780702 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11475546 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11368133 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10138755 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08110709 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06915615 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06389844 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05995775 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05325103 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03354816 |
| 77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03014261 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02100602 |
| 79 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00759909 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00395645 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98866875 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98831831 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97495831 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95838332 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95308111 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95221805 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94868049 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94369026 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93867819 |
| 90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93724790 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92309680 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91813824 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91106021 |
| 94 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.90226871 |
| 95 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89603954 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89145246 |
| 97 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88438495 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86945763 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86017198 |
| 100 | * P68_20966046_ChIP-Seq_HELA_Human | 0.83936908 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83420070 |
| 102 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.83069245 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82680294 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81161220 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79341363 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78683764 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78581975 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.77495414 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77399560 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.76554392 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.76227179 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74862462 |
| 113 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73222537 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69790222 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68832946 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68479069 |
| 117 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.67275066 |
| 118 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.66144548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.51892680 |
| 2 | MP0009785_altered_susceptibility_to | 4.09502397 |
| 3 | MP0003724_increased_susceptibility_to | 3.49765827 |
| 4 | MP0000685_abnormal_immune_system | 3.22605506 |
| 5 | MP0005671_abnormal_response_to | 3.13246670 |
| 6 | MP0003436_decreased_susceptibility_to | 3.08919687 |
| 7 | MP0001790_abnormal_immune_system | 3.06201842 |
| 8 | MP0005387_immune_system_phenotype | 3.06201842 |
| 9 | MP0006082_CNS_inflammation | 3.05363355 |
| 10 | * MP0005025_abnormal_response_to | 3.00815014 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.85224439 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.81294710 |
| 13 | MP0004510_myositis | 2.74862693 |
| 14 | MP0003303_peritoneal_inflammation | 2.70602373 |
| 15 | MP0001800_abnormal_humoral_immune | 2.65687728 |
| 16 | MP0002419_abnormal_innate_immunity | 2.59510910 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.51544844 |
| 18 | * MP0002723_abnormal_immune_serum | 2.49443809 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.48882065 |
| 20 | MP0004947_skin_inflammation | 2.30174006 |
| 21 | * MP0001819_abnormal_immune_cell | 2.24301180 |
| 22 | * MP0002420_abnormal_adaptive_immunity | 2.21064745 |
| 23 | MP0002006_tumorigenesis | 2.16916007 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.01342371 |
| 25 | MP0009840_abnormal_foam_cell | 1.99383430 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.97060972 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.96577609 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.91807997 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.86602867 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.85856402 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.82583816 |
| 32 | * MP0008469_abnormal_protein_level | 1.81869958 |
| 33 | MP0002405_respiratory_system_inflammati | 1.81757901 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.80001497 |
| 35 | MP0005451_abnormal_body_composition | 1.74402268 |
| 36 | MP0001853_heart_inflammation | 1.73914199 |
| 37 | MP0000716_abnormal_immune_system | 1.73906025 |
| 38 | MP0002398_abnormal_bone_marrow | 1.71408773 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.67995549 |
| 40 | MP0009764_decreased_sensitivity_to | 1.66697758 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.65680696 |
| 42 | MP0000343_altered_response_to | 1.62152366 |
| 43 | MP0003448_altered_tumor_morphology | 1.61732835 |
| 44 | MP0005310_abnormal_salivary_gland | 1.45194522 |
| 45 | MP0002429_abnormal_blood_cell | 1.41138895 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.38838313 |
| 47 | MP0002722_abnormal_immune_system | 1.36131114 |
| 48 | MP0005360_urolithiasis | 1.32904589 |
| 49 | MP0000858_altered_metastatic_potential | 1.29683537 |
| 50 | MP0002933_joint_inflammation | 1.22208813 |
| 51 | MP0001873_stomach_inflammation | 1.21951277 |
| 52 | MP0008260_abnormal_autophagy | 1.21334418 |
| 53 | MP0000604_amyloidosis | 1.20407881 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.20351842 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.19638746 |
| 56 | MP0009278_abnormal_bone_marrow | 1.18854536 |
| 57 | MP0003075_altered_response_to | 1.17963364 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.17900563 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.17900563 |
| 60 | MP0009763_increased_sensitivity_to | 1.12253794 |
| 61 | MP0005083_abnormal_biliary_tract | 1.08834815 |
| 62 | MP0002254_reproductive_system_inflammat | 1.04802047 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.04739846 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.04414564 |
| 65 | MP0008004_abnormal_stomach_pH | 1.04126652 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.03085316 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.00849363 |
| 68 | MP0003690_abnormal_glial_cell | 0.96408970 |
| 69 | MP0001851_eye_inflammation | 0.95729635 |
| 70 | MP0005023_abnormal_wound_healing | 0.95349785 |
| 71 | MP0003866_abnormal_defecation | 0.93587248 |
| 72 | MP0001663_abnormal_digestive_system | 0.93520451 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.93156823 |
| 74 | MP0000609_abnormal_liver_physiology | 0.92414689 |
| 75 | MP0005166_decreased_susceptibility_to | 0.92257633 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.91837896 |
| 77 | MP0003186_abnormal_redox_activity | 0.91823392 |
| 78 | MP0003045_fibrosis | 0.88764861 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.88434632 |
| 80 | MP0000249_abnormal_blood_vessel | 0.85585703 |
| 81 | MP0004883_abnormal_blood_vessel | 0.84594068 |
| 82 | MP0005390_skeleton_phenotype | 0.81205990 |
| 83 | MP0005164_abnormal_response_to | 0.80974976 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.74371079 |
| 85 | MP0004858_abnormal_nervous_system | 0.73241943 |
| 86 | MP0010307_abnormal_tumor_latency | 0.72888333 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.72161828 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.72002136 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.71809200 |
| 90 | MP0008874_decreased_physiological_sensi | 0.71242774 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.71153619 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.69342794 |
| 93 | MP0003091_abnormal_cell_migration | 0.68791151 |
| 94 | MP0001958_emphysema | 0.67685248 |
| 95 | MP0002132_abnormal_respiratory_system | 0.67101831 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.66537224 |
| 97 | MP0001881_abnormal_mammary_gland | 0.66298173 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65925469 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.64074656 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.64034645 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.63976585 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.63693337 |
| 103 | MP0003828_pulmonary_edema | 0.62923257 |
| 104 | MP0009643_abnormal_urine_homeostasis | 0.62908101 |
| 105 | MP0003795_abnormal_bone_structure | 0.62312835 |
| 106 | MP0003252_abnormal_bile_duct | 0.62001133 |
| 107 | MP0010234_abnormal_vibrissa_follicle | 0.61194475 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.61132340 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.60916343 |
| 110 | MP0000598_abnormal_liver_morphology | 0.60402668 |
| 111 | MP0006054_spinal_hemorrhage | 0.59541863 |
| 112 | MP0000490_abnormal_crypts_of | 0.59458359 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.56317334 |
| 114 | MP0005165_increased_susceptibility_to | 0.55581658 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.54389640 |
| 116 | MP0005535_abnormal_body_temperature | 0.50390899 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.49824635 |
| 118 | MP0001542_abnormal_bone_strength | 0.49694267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.92364012 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.77567943 |
| 3 | Chronic otitis media (HP:0000389) | 5.51058738 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.33601475 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.75100792 |
| 6 | Myositis (HP:0100614) | 4.61051633 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.51201281 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.47214832 |
| 9 | Nasal polyposis (HP:0100582) | 4.39388501 |
| 10 | Abnormality of the nasal mucosa (HP:0000433) | 4.31295680 |
| 11 | Orchitis (HP:0100796) | 4.13213294 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.08048792 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.03193635 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.96327830 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.90047530 |
| 16 | Increased IgM level (HP:0003496) | 3.72756114 |
| 17 | Recurrent skin infections (HP:0001581) | 3.69744952 |
| 18 | Optic neuritis (HP:0100653) | 3.63707967 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.63707967 |
| 20 | Recurrent viral infections (HP:0004429) | 3.61753804 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.56579320 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.56579320 |
| 23 | Vasculitis (HP:0002633) | 3.50390961 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 3.47962938 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.42634081 |
| 26 | Stomatitis (HP:0010280) | 3.41096409 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37696274 |
| 28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37696274 |
| 29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37696274 |
| 30 | Encephalitis (HP:0002383) | 3.31334924 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.30102935 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.26419467 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 3.25881113 |
| 34 | Agammaglobulinemia (HP:0004432) | 3.22309598 |
| 35 | Basal ganglia calcification (HP:0002135) | 3.18628898 |
| 36 | Gingivitis (HP:0000230) | 3.13358569 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 3.06968573 |
| 38 | Chronic sinusitis (HP:0011109) | 3.05311386 |
| 39 | Pustule (HP:0200039) | 2.98773976 |
| 40 | Increased cerebral lipofuscin (HP:0011813) | 2.98417372 |
| 41 | Hemoptysis (HP:0002105) | 2.80820715 |
| 42 | Colitis (HP:0002583) | 2.79783774 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.76833726 |
| 44 | Loss of speech (HP:0002371) | 2.74004346 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.72846175 |
| 46 | Abnormality of B cell number (HP:0010975) | 2.70858946 |
| 47 | Increased IgE level (HP:0003212) | 2.69649216 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68092656 |
| 49 | Obstructive lung disease (HP:0006536) | 2.68092656 |
| 50 | Leukocytosis (HP:0001974) | 2.66736044 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65840780 |
| 52 | Tetraparesis (HP:0002273) | 2.65616169 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.63614352 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.60181318 |
| 55 | B lymphocytopenia (HP:0010976) | 2.59290724 |
| 56 | Gangrene (HP:0100758) | 2.57525289 |
| 57 | Recurrent pneumonia (HP:0006532) | 2.55344848 |
| 58 | Urticaria (HP:0001025) | 2.54824737 |
| 59 | Abnormality of T cells (HP:0002843) | 2.54582936 |
| 60 | Abnormality of the pleura (HP:0002103) | 2.52542622 |
| 61 | T lymphocytopenia (HP:0005403) | 2.51635235 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.51473920 |
| 63 | Petechiae (HP:0000967) | 2.49938619 |
| 64 | Gingival bleeding (HP:0000225) | 2.49133355 |
| 65 | Hematochezia (HP:0002573) | 2.49027468 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.47821513 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.44985093 |
| 68 | Cellulitis (HP:0100658) | 2.43841148 |
| 69 | Periodontitis (HP:0000704) | 2.42173527 |
| 70 | Chest pain (HP:0100749) | 2.41403570 |
| 71 | Meningitis (HP:0001287) | 2.39080232 |
| 72 | Myocardial infarction (HP:0001658) | 2.38914446 |
| 73 | Sepsis (HP:0100806) | 2.38447961 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.38379469 |
| 75 | Arterial thrombosis (HP:0004420) | 2.38051201 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.36419965 |
| 77 | Eosinophilia (HP:0001880) | 2.35886366 |
| 78 | Joint swelling (HP:0001386) | 2.35232847 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.33527199 |
| 80 | Porencephaly (HP:0002132) | 2.33382116 |
| 81 | Glomerulonephritis (HP:0000099) | 2.32245389 |
| 82 | Combined immunodeficiency (HP:0005387) | 2.30986182 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 2.30871951 |
| 84 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29908278 |
| 85 | IgA deficiency (HP:0002720) | 2.29479546 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.29375565 |
| 87 | Purpura (HP:0000979) | 2.29319571 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.28620000 |
| 89 | Lymphopenia (HP:0001888) | 2.28124877 |
| 90 | Emphysema (HP:0002097) | 2.27461264 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.24595105 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.23941646 |
| 93 | Restrictive lung disease (HP:0002091) | 2.23766480 |
| 94 | Nephritis (HP:0000123) | 2.22547776 |
| 95 | Chronic diarrhea (HP:0002028) | 2.20227504 |
| 96 | Anorexia (HP:0002039) | 2.20164186 |
| 97 | IgG deficiency (HP:0004315) | 2.18404546 |
| 98 | Cheilitis (HP:0100825) | 2.16910262 |
| 99 | Bronchitis (HP:0012387) | 2.16376115 |
| 100 | Episodic fever (HP:0001954) | 2.15633662 |
| 101 | Dysostosis multiplex (HP:0000943) | 2.15549587 |
| 102 | Prolonged bleeding time (HP:0003010) | 2.11910944 |
| 103 | Skin ulcer (HP:0200042) | 2.11406749 |
| 104 | Abnormality of the pericardium (HP:0001697) | 2.10661273 |
| 105 | Malnutrition (HP:0004395) | 2.10517592 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.10374146 |
| 107 | Disinhibition (HP:0000734) | 2.10299328 |
| 108 | Arthralgia (HP:0002829) | 2.10287316 |
| 109 | Complement deficiency (HP:0004431) | 2.10053537 |
| 110 | Osteomyelitis (HP:0002754) | 2.05923417 |
| 111 | Granulocytopenia (HP:0001913) | 2.05815677 |
| 112 | Hypertensive crisis (HP:0100735) | 2.05167397 |
| 113 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05116844 |
| 114 | Hepatosplenomegaly (HP:0001433) | 2.04650033 |
| 115 | Abnormality of the peritoneum (HP:0002585) | 2.04578932 |
| 116 | IgM deficiency (HP:0002850) | 2.04327560 |
| 117 | Increased serum ferritin (HP:0003281) | 2.03365451 |
| 118 | Epistaxis (HP:0000421) | 2.02697022 |
| 119 | Polyneuropathy (HP:0001271) | 2.02641100 |
| 120 | Joint hemorrhage (HP:0005261) | 2.00643095 |
| 121 | Thyroiditis (HP:0100646) | 1.99473743 |
| 122 | Pulmonary embolism (HP:0002204) | 1.97139129 |
| 123 | Amyloidosis (HP:0011034) | 1.95236283 |
| 124 | Esophageal varix (HP:0002040) | 1.94719164 |
| 125 | Axonal loss (HP:0003447) | 1.94175514 |
| 126 | Thick nail (HP:0001805) | 1.93395457 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92355601 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.92355601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.75893006 |
| 2 | FGFR4 | 4.23954946 |
| 3 | MAP3K14 | 3.53878244 |
| 4 | KIT | 3.52012434 |
| 5 | JAK3 | 3.24197464 |
| 6 | * TBK1 | 3.23268483 |
| 7 | MAP4K1 | 3.17927624 |
| 8 | * IKBKE | 3.17309034 |
| 9 | JAK1 | 2.99789735 |
| 10 | BLK | 2.78465405 |
| 11 | ERN1 | 2.78463366 |
| 12 | PRPF4B | 2.56709190 |
| 13 | TXK | 2.50216977 |
| 14 | FGFR3 | 2.25422127 |
| 15 | IRAK4 | 2.18959505 |
| 16 | EPHB1 | 2.00834468 |
| 17 | ZAP70 | 1.93470759 |
| 18 | IKBKB | 1.93296933 |
| 19 | TAOK2 | 1.83768898 |
| 20 | KDR | 1.80655931 |
| 21 | TAOK1 | 1.74852699 |
| 22 | TNK2 | 1.72907432 |
| 23 | CSK | 1.72826680 |
| 24 | EPHA3 | 1.71687155 |
| 25 | MAP3K13 | 1.69355138 |
| 26 | GRK7 | 1.61984344 |
| 27 | IRAK3 | 1.60603080 |
| 28 | PIM2 | 1.50110134 |
| 29 | NME2 | 1.44727963 |
| 30 | RIPK4 | 1.37659941 |
| 31 | PBK | 1.36484719 |
| 32 | LCK | 1.35536809 |
| 33 | HCK | 1.33767453 |
| 34 | CSF1R | 1.26728540 |
| 35 | SYK | 1.26133441 |
| 36 | BTK | 1.21210965 |
| 37 | JAK2 | 1.21112857 |
| 38 | CHUK | 1.20672063 |
| 39 | TEC | 1.19673530 |
| 40 | BMPR2 | 1.12930141 |
| 41 | TGFBR2 | 1.10686697 |
| 42 | MST4 | 1.09881413 |
| 43 | MOS | 1.06447784 |
| 44 | TAOK3 | 1.06380075 |
| 45 | CDC42BPA | 1.06252583 |
| 46 | NLK | 1.05852240 |
| 47 | FES | 1.01254994 |
| 48 | RPS6KA4 | 1.00497558 |
| 49 | ITK | 0.97924053 |
| 50 | SMG1 | 0.95459176 |
| 51 | STK10 | 0.92986556 |
| 52 | LYN | 0.92557893 |
| 53 | PTK6 | 0.85200400 |
| 54 | LRRK2 | 0.84816798 |
| 55 | MAPK11 | 0.83350267 |
| 56 | FLT3 | 0.83024315 |
| 57 | IRAK1 | 0.82345801 |
| 58 | SIK2 | 0.80791717 |
| 59 | GRK6 | 0.79976861 |
| 60 | TESK2 | 0.79958747 |
| 61 | TRIB3 | 0.79895463 |
| 62 | IRAK2 | 0.79111264 |
| 63 | DDR2 | 0.77216825 |
| 64 | MATK | 0.76967064 |
| 65 | FGR | 0.72295617 |
| 66 | MAP3K11 | 0.68875465 |
| 67 | MAP3K10 | 0.64611714 |
| 68 | PIM1 | 0.63770402 |
| 69 | NEK9 | 0.61399380 |
| 70 | BMX | 0.60990033 |
| 71 | MARK2 | 0.60577612 |
| 72 | PRKD2 | 0.60177048 |
| 73 | MAPK7 | 0.60171013 |
| 74 | MAP2K3 | 0.59753479 |
| 75 | PKN2 | 0.59721544 |
| 76 | RIPK1 | 0.59240261 |
| 77 | TESK1 | 0.58263187 |
| 78 | EGFR | 0.56648885 |
| 79 | KSR2 | 0.54824861 |
| 80 | MARK3 | 0.53598126 |
| 81 | MAP3K1 | 0.53105152 |
| 82 | SIK1 | 0.52206307 |
| 83 | ABL1 | 0.51847232 |
| 84 | PRKCD | 0.51692552 |
| 85 | ABL2 | 0.51493416 |
| 86 | MAP3K5 | 0.48919553 |
| 87 | TGFBR1 | 0.48618405 |
| 88 | MAP3K3 | 0.48355333 |
| 89 | DAPK3 | 0.47200702 |
| 90 | PRKCQ | 0.46945167 |
| 91 | MAP3K12 | 0.46773632 |
| 92 | MST1R | 0.46388663 |
| 93 | TTN | 0.45934973 |
| 94 | RPS6KA5 | 0.45837155 |
| 95 | MAP2K6 | 0.43179911 |
| 96 | CDK4 | 0.43047224 |
| 97 | PRKG2 | 0.42642158 |
| 98 | MAPK12 | 0.42457779 |
| 99 | MAP3K8 | 0.42214586 |
| 100 | EIF2AK2 | 0.42138476 |
| 101 | SIK3 | 0.40346878 |
| 102 | PRKCH | 0.39447376 |
| 103 | RPS6KC1 | 0.37271698 |
| 104 | RPS6KL1 | 0.37271698 |
| 105 | DYRK1B | 0.35705152 |
| 106 | ADRBK2 | 0.33454862 |
| 107 | TIE1 | 0.33188003 |
| 108 | FYN | 0.32441051 |
| 109 | MAPKAPK2 | 0.30827185 |
| 110 | IGF1R | 0.29951127 |
| 111 | RPS6KA6 | 0.28562782 |
| 112 | TLK1 | 0.28089984 |
| 113 | INSR | 0.25766777 |
| 114 | MAPK4 | 0.25412392 |
| 115 | YES1 | 0.24027305 |
| 116 | STK4 | 0.23438319 |
| 117 | PDK1 | 0.23145967 |
| 118 | SRC | 0.22825577 |
| 119 | PAK4 | 0.22281465 |
| 120 | MAP3K6 | 0.21470637 |
| 121 | HIPK2 | 0.20182669 |
| 122 | CDK6 | 0.16859016 |
| 123 | PDPK1 | 0.16797384 |
| 124 | ARAF | 0.16459271 |
| 125 | MAPK3 | 0.15654938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.17415655 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.02898588 |
| 3 | * Measles_Homo sapiens_hsa05162 | 2.74796062 |
| 4 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.69161500 |
| 5 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.68762543 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.64913784 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64138360 |
| 8 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.61778274 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.41915048 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37496722 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32097149 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30038151 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28596309 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.24000314 |
| 15 | * Influenza A_Homo sapiens_hsa05164 | 2.10052458 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.03649882 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02330827 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.00906112 |
| 19 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.96832480 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.95829120 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.84457890 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.78146364 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72390451 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71616098 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.71038584 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63386047 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61905922 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54738955 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54367537 |
| 30 | * Hepatitis C_Homo sapiens_hsa05160 | 1.41381263 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.40174918 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39968110 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37942231 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36938558 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33693326 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.33210732 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.32599988 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.32437441 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31068356 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.28938113 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23018346 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19580177 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15151963 |
| 44 | * Hepatitis B_Homo sapiens_hsa05161 | 1.14180940 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11466248 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.07470931 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.04294928 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02420855 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02350078 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02222525 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01933522 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00127930 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91280394 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89778705 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86891519 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.81758823 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78202048 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78125674 |
| 59 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77958691 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74150458 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71246059 |
| 62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68299621 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66289755 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.66017626 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65114150 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.64242112 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52390370 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.51839962 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.51230900 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50766542 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.50116942 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49876557 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.49033296 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48938104 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46205450 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.45085189 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42014096 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41934301 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.39915861 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39853072 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39529629 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38470878 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37150644 |
| 84 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35861233 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34630002 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34061041 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33512637 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33245438 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31157183 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30485575 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.29896134 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29894909 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29735327 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29599286 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.29306224 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.28901824 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.28397081 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27704515 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27102481 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24777846 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23659518 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.21306083 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20908730 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.20834296 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20601573 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20591502 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17021852 |
| 108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.15851856 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.14939599 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13405109 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12590755 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.12416243 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11560309 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11383726 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11376568 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10689359 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10040107 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.09210437 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08545155 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07661890 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.06010415 |

